677 research outputs found

    Thermal Transport Study on Actinide Oxides using Phonon Density of States Calculation

    Get PDF
    The thermophysical properties of nuclear fuels being developed in generation IV nuclear reactors are still being widely examined since the reactor’s operating performance is strongly correlated to the thermal transport properties of the fuel source. In this research, phonon density of states (DOS) are estimated for uranium dioxide (UO2), thorium dioxide (ThO2), and plutonium dioxide (PuO2) as these are all significant representations of the actinide oxide family. The crystalline structures of these fuels are altered to contain point defects in the form of primary atom vacancies, oxygen vacancies, and uranium substitution. Primary atom and oxygen vacancies involve a set percentage (0.1%, 0.5%, 1%, 2%, and 5%) of atoms being removed from the lattice structure of each fuel, while the uranium substitution in ThO2 and PuO2 replaces a set percentage of primary atoms with uranium-238 atoms. Phonon DOS are plotted using molecular dynamics simulations and the Fourier transform of the velocity autocorrelation function of atoms. The results show that phonon DOS is altered greatly by the presence of any form of vacancy defects; a significant change in DOS is observed in low frequency regime (~20 meV) where most of important energy carriers (phonons) are activated, and this explains the significant reduction in thermal conductivity in nuclear fuels by vacancy defects. Also, it is found that the change in phonon DOS by oxygen vacancies is smaller than that by primary atom vacancies, supporting our previous results that showed that the thermal conductivity is reduced by primary atom vacancies more than by oxygen vacancies. The most interesting observation is made on nuclear fuels with uranium substitution that shows very little variance in phonon DOS; the very small decrease in the thermal conductivities of PuO2 and ThO2 by uranium substitution results from their minimal alteration to lattice vibration

    Learning Users’ Interests in a Market-Based Recommender System

    Full text link
    Recommender systems are widely used to cope with the problem of information overload and, consequently, many recommendation methods have been developed. However, no one technique is best for all users in all situations. To combat this, we have previously developed a market-based recommender system that allows multiple agents (each representing a different recommendation method or system) to compete with one another to present their best recommendations to the user. Our marketplace thus coordinates multiple recommender agents and ensures only the best recommendations are presented. To do this effectively, however, each agent needs to learn the users’ interests and adapt its recommending behaviour accordingly. To this end, in this paper, we develop a reinforcement learning and Boltzmann exploration strategy that the recommender agents can use for these tasks. We then demonstrate that this strategy helps the agents to effectively obtain information about the users’ interests which, in turn, speeds up the market convergence and enables the system to rapidly highlight the best recommendations

    Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications

    Get PDF
    Age is the main clinical determinant of large artery stiffness. Central arteries stiffen progressively with age, whereas peripheral muscular arteries change little with age. A number of clinical studies have analyzed the effects of age on aortic stiffness. Increase of central artery stiffness with age is responsible for earlier wave reflections and changes in pressure wave contours. The stiffening of aorta and other central arteries is a potential risk factor for increased cardiovascular morbidity and mortality. Arterial stiffening with aging is accompanied by an elevation in systolic blood pressure (BP) and pulse pressure (PP). Although arterial stiffening with age is a common situation, it has now been confirmed that older subjects with increased arterial stiffness and elevated PP have higher cardiovascular morbidity and mortality. Increase in aortic stiffness with age occurs gradually and continuously, similarly for men and women. Cross-sectional studies have shown that aortic and carotid stiffness (evaluated by the pulse wave velocity) increase with age by approximately 10% to 15% during a period of 10 years. Women always have 5% to 10% lower stiffness than men of the same age. Although large artery stiffness increases with age independently of the presence of cardiovascular risk factors or other associated conditions, the extent of this increase may depend on several environmental or genetic factors. Hypertension may increase arterial stiffness, especially in older subjects. Among other cardiovascular risk factors, diabetes type 1 and 2 accelerates arterial stiffness, whereas the role of dyslipidemia and tobacco smoking is unclear. Arterial stiffness is also present in several cardiovascular and renal diseases. Patients with heart failure, end stage renal disease, and those with atherosclerotic lesions often develop central artery stiffness. Decreased carotid distensibility, increased arterial thickness, and presence of calcifications and plaques often coexist in the same subject. However, relationships between these three alterations of the arterial wall remain to be explored. Am J Hypertens 2002;15:1101-1108 © 2002 American Journal of Hypertension, Lt

    DNA strand break repair and neurodegeneration.

    Get PDF
    A number of DNA repair disorders are known to cause neurological problems. These disorders can be broadly characterised into early developmental, mid-to-late developmental or progressive. The exact developmental processes that are affected can influence disease pathology, with symptoms ranging from early embryonic lethality to late-onset ataxia. The category these diseases belong to depends on the frequency of lesions arising in the brain, the role of the defective repair pathway, and the nature of the mutation within the patient. Using observations from patients and transgenic mice, we discuss the importance of double strand break repair during neuroprogenitor proliferation and brain development and the repair of single stranded lesions in neuronal function and maintenance

    Walk well:a randomised controlled trial of a walking intervention for adults with intellectual disabilities: study protocol

    Get PDF
    Background - Walking interventions have been shown to have a positive impact on physical activity (PA) levels, health and wellbeing for adult and older adult populations. There has been very little work carried out to explore the effectiveness of walking interventions for adults with intellectual disabilities. This paper will provide details of the Walk Well intervention, designed for adults with intellectual disabilities, and a randomised controlled trial (RCT) to test its effectiveness. Methods/design - This study will adopt a RCT design, with participants allocated to the walking intervention group or a waiting list control group. The intervention consists of three PA consultations (baseline, six weeks and 12 weeks) and an individualised 12 week walking programme. A range of measures will be completed by participants at baseline, post intervention (three months from baseline) and at follow up (three months post intervention and six months from baseline). All outcome measures will be collected by a researcher who will be blinded to the study groups. The primary outcome will be steps walked per day, measured using accelerometers. Secondary outcome measures will include time spent in PA per day (across various intensity levels), time spent in sedentary behaviour per day, quality of life, self-efficacy and anthropometric measures to monitor weight change. Discussion - Since there are currently no published RCTs of walking interventions for adults with intellectual disabilities, this RCT will examine if a walking intervention can successfully increase PA, health and wellbeing of adults with intellectual disabilities

    Behavioral characterization of a mouse model overexpressing DSCR1/ RCAN1

    Get PDF
    DSCR1/ RCAN1 is a chromosome 21 gene found to be overexpressed in the brains of Down syndrome (DS) and postulated as a good candidate to contribute to mental disability. However, even though Rcan1 knockout mice have pronounced spatial learning and memory deficits, the possible deleterious effects of its overexpression in DS are not well understood. We have generated a transgenic mouse model overexpressing DSCR1/RCAN1 in the brain and analyzed the effect of RCAN1 overexpression on cognitive function. TgRCAN1 mice present a marked disruption of the learning process in a visuo-spatial learning task. However, no significant differences were observed in the performance of the memory phase of the test (removal session) nor in a step-down passive avoidance task, thus suggesting that once learning has been established, the animals are able to consolidate the information in the longer term

    Changing practice in dementia care in the community: developing and testing evidence-based interventions, from timely diagnosis to end of life (EVIDEM)

    Get PDF
    Background Dementia has an enormous impact on the lives of individuals and families, and on health and social services, and this will increase as the population ages. The needs of people with dementia and their carers for information and support are inadequately addressed at all key points in the illness trajectory. Methods The Unit is working specifically on an evaluation of the impact of the Mental Capacity Act 2005, and will develop practice guidance to enhance concordance with the Act. Phase One of the study has involved baseline interviews with practitioners across a wide range of services to establish knowledge and expectations of the Act, and to consider change processes when new policy and legislation are implemented. Findings Phase 1, involving baseline interviews with 115 practitioners, identified variable knowledge and understanding about the principles of the Act. Phase 2 is exploring everyday decision-making by people with memory problems and their carers

    Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies

    Get PDF
    Circulating miRNAs (microRNAs) are emerging as promising biomarkers for several pathological conditions, and the aim of this study was to investigate the feasibility of using serum miRNAs as biomarkers for liver pathologies. Real-time qPCR (quantitative PCR)-based TaqMan MicroRNA arrays were first employed to profile miRNAs in serum pools from patients with HCC (hepatocellular carcinoma) or LC (liver cirrhosis) and from healthy controls. Five miRNAs (i.e. miR-885-5p, miR-574-3p, miR-224, miR-215 and miR-146a) that were up-regulated in the HCC and LC serum pools were selected and further quantified using real-time qPCR in patients with HCC, LC, CHB (chronic hepatitis B) or GC (gastric cancer) and in normal controls. The present study revealed that more than 110 miRNA species in the serum samples and wide distribution ranges of serum miRNAs were observed. The levels of miR-885-5p were significantly higher in sera from patients with HCC, LC and CHB than in healthy controls or GC patients. miR-885-5p yielded an AUC [the area under the ROC (receiver operating characteristic) curve] of 0.904 [95% CI (confidence interval), 0.837–0.951, P<0.0001) with 90.53% sensitivity and 79.17% specificity in discriminating liver pathologies from healthy controls, using a cut off value of 1.06 (normalized). No correlations between increased miR-885-5p and liver function parameters [AFP (α-fetoprotein), ALT (alanine aminotransferase), AST (aspartate aminotransferase) and GGT (γ-glutamyl transpeptidase)] were observed in patients with liver pathologies. In summary, miR-885-5p is significantly elevated in the sera of patients with liver pathologies, and our data suggest that serum miRNAs could serve as novel complementary biomarkers for the detection and assessment of liver pathologies
    corecore